Research and Markets (http://www.researchandmarkets.com/research/vcngmn/global) has announced the addition of the "Global Fibromyalgia Epidemiology and Patient Flow Analysis - 2016" report to their offering.

The report provides insights into Fibromyalgia epidemiology, Fibromyalgia diagnosed patients, and Fibromyalgia treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Fibromyalgia derived from epidemiological analysis, percentage of patients diagnosed with Fibromyalgia, and percentage of patients treated with Fibromyalgia therapy.

The study helps executives estimate Fibromyalgia market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Fibromyalgia prevalence, Fibromyalgia diagnosis rate, and Fibromyalgia treatment rate for the period 2015 - 2022. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Features of the Report:

  • Fibromyalgia: Disease Definition
  • Fibromyalgia Patient Flow
  • Fibromyalgia Prevalence
  • Fibromyalgia Diagnosed Patients
  • Fibromyalgia Treated Patients

Key Topics Covered:

1. Fibromyalgia: Disease Definition

2. Global Fibromyalgia Patient Flow

3. Fibromyalgia Patient Flow in the US

4. Fibromyalgia Patient Flow in Europe

5. Fibromyalgia Patient Flow in Germany

6. Fibromyalgia Patient Flow in France

7. Fibromyalgia Patient Flow in Spain

8. Fibromyalgia Patient Flow in Italy

9. Fibromyalgia Patient Flow in UK

10. Fibromyalgia Patient Flow in Japan

11. Appendix

For more information visit http://www.researchandmarkets.com/research/vcngmn/global